Učitavanje...
Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Previously, it was found that 5‐ASA drugs were more effective than placebo but had a statistically significant therapeutic inferiority...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2016
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045447/ https://ncbi.nlm.nih.gov/pubmed/27158764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000544.pub4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|